戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  of a highly conserved amino acid residue in beta-tropomyosin.
2 t found to regulate mRNA splicing in chicken beta-tropomyosin.
3 und that Rad interacted with skeletal muscle beta-tropomyosin.
4 ical contexts not previously associated with beta-tropomyosin.
5 tion identified in the extreme N-terminus of beta-tropomyosin.
6 e N-terminus of the alpha-helices of dimeric beta-tropomyosin, a change predicted to alter protein-pr
7      A human homologue of Tm2, TPM2, encodes beta-tropomyosin and maps to the critical interval of DA
8 ted to alter protein-protein binding between beta-tropomyosin and other molecules and to disturb head
9 al phenotypes not previously associated with beta-tropomyosin and pathogenic data from the first anim
10 lude that Rad interacts with skeletal muscle beta-tropomyosin and the cytoskeleton in a guanine nucle
11 oma tumor supressor gene, M creatine kinase, beta-tropomyosin, and vimentin.
12                                   In the rat beta-tropomyosin (beta-TM) gene, exons 6 and 7 are splic
13 eins troponin T (TnT), troponin I (TnI), and beta-tropomyosin (beta-TM) have been shown to cause auto
14                        Deletion of Glu139 in beta-tropomyosin caused by a point mutation in TPM2 gene
15 nd to disturb head-to-tail polymerization of beta-tropomyosin dimers.
16                         Results show that as beta-tropomyosin expression is down-regulated, alpha-tro
17                                      p.K7del beta-tropomyosin fails to localize properly within the t
18                                          The beta-tropomyosin gene encodes a component of the sarcome
19 g INS), an exonic splicing silencer from the beta-tropomyosin gene, and an intronic splicing regulato
20 ivo model, we expressed wild-type or p.K7del beta-tropomyosin in the developing zebrafish.
21 zed a transgenic mouse system to overexpress beta-tropomyosin in the heart to address the functional
22 tropomodulin, myosin light chain-2, or fetal beta-tropomyosin in the heart.
23 study, we have rescued these high expression beta-tropomyosin mice by turning off the alpha-myosin he
24 athies through the identification of a novel beta-tropomyosin mutation in two clinical contexts not p
25 nical phenotype is core-rod myopathy, with a beta-tropomyosin mutation uncovered by whole exome seque
26                          We describe a novel beta-tropomyosin mutation, two clinical-histopathologica
27 yosin regulate actin-myosin interactions and beta-tropomyosin mutations have been associated with nem
28 at the mutation interferes with head-to-tail beta-tropomyosin polymerization and with overall sarcome
29 his study, we expand the allelic spectrum of beta-tropomyosin-related myopathies through the identifi
30 thogenic data from the first animal model of beta-tropomyosin-related myopathies.
31     Interestingly, when a high percentage of beta-tropomyosin replaces alpha-tropomyosin in the heart
32 family binds the WA1, instability (INS), and beta-tropomyosin substrates, and the core-binding site f
33 onic sequence, an (A/U)GGG repeat in chicken beta-tropomyosin that is a binding site for a protein re
34 nt charge differences between the alpha- and beta-tropomyosin (TM) isoforms are the exchange of a ser
35 n heavy chain promoter, which is driving the beta-tropomyosin transgene.
36 y lethal phenotypes, such as high expression beta-tropomyosin transgenic mice.
37 ein phenotype that expresses both alpha- and beta-tropomyosin, very low levels of SERCA2a, and very l
38  expressed in striated muscle are alpha- and beta-tropomyosin, which exhibit an 86% amino acid identi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。